Qube Research & Technologies Ltd - ALDEYRA THERAPEUTICS INC ownership

ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 97 filers reported holding ALDEYRA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 1.35 and the average weighting 0.4%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of ALDEYRA THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$780,061
+97.3%
78,556
+38.3%
0.00%
+50.0%
Q4 2022$395,460
+107.0%
56,819
+59.0%
0.00%
+100.0%
Q3 2022$191,000
+148.1%
35,728
+84.0%
0.00%0.0%
Q2 2022$77,000
-79.8%
19,415
-55.3%
0.00%
-80.0%
Q3 2021$382,000
-30.4%
43,459
-10.4%
0.01%
-16.7%
Q2 2021$549,000
-19.6%
48,498
-15.7%
0.01%
-45.5%
Q1 2021$683,000
-34.6%
57,502
-62.2%
0.01%
-26.7%
Q4 2020$1,044,000
+221.2%
152,189
+246.8%
0.02%
+200.0%
Q3 2020$325,000
+277.9%
43,886
+112.7%
0.01%
+400.0%
Q2 2020$86,00020,6300.00%
Other shareholders
ALDEYRA THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Prosight Management, LP 473,446$5,625,0004.61%
Knoll Capital Management, LLC 569,405$6,765,0004.41%
SILVERARC CAPITAL MANAGEMENT, LLC 321,879$3,824,0002.09%
First Light Asset Management, LLC 2,624,001$31,173,0002.07%
Mesirow Financial Investment Management, Inc. 63,634$756,0002.06%
Ghost Tree Capital, LLC 650,000$7,722,0001.82%
Altium Capital Management LP 548,225$6,513,0001.81%
Perceptive Advisors 8,703,879$103,402,0001.31%
Affinity Asset Advisors, LLC 300,000$3,564,0001.21%
Avidity Partners Management LP 2,552,000$30,318,0000.84%
View complete list of ALDEYRA THERAPEUTICS INC shareholders